Expected Moves

With the US fiscal year beginning, the market awaits final defense appropriations from the Trump administration. Given BAE generates roughly 45% of its revenue from the US, favorable budget allocations for naval upgrades and combat vehicle modernization can push shares to a $26.80 target, while delays or continuing resolutions risk a slide to $24.10.

BAE typically issues a Q3 trading update in November. We are tracking backlog momentum in Eurofighter and MBDA orders. Strong intake lifts the stock to $28.00, challenging its 52-week high, whereas sluggish order conversion sends it down to $24.80.

Expected early-2027 decisions on Middle East Eurofighter export tranches and GCAP (Tempest) R&D funding allocations by the UK/Japan/Italy coalition. Favorable export clarity drives the stock to $29.50, while delayed government commitments drop the baseline to $26.00.

BAE's mandatory FY26 earnings print. The focus is squarely on 2027 EBIT margin guidance and the next iteration of the share buyback program. A beat-and-raise achieves a $31.00 target; a weak guide triggering multiple compression sinks shares to $26.80.

Mid-Q2 industry read-throughs on titanium shortages and skilled labor constraints. If BAE navigates these without fixed-price maritime contract write-downs, shares drift to a $32.00 target. If inflationary pressures force margin warnings, the stock resets to a $28.50 fallback.

First-half 2027 actuals. Investors will assess whether order intake from AUKUS and European ground systems (CV90) translated into top-line acceleration. Clean execution yields a $30.00 target; a miss on cash conversion drags the stock to $26.20.